Indications for NULECIT:

Iron deficiency anemia in patients on chronic hemodialysis receiving epoetin therapy.

Adult Dosage:

Give by IV infusion (diluted) or slow IV inj (undiluted). 125mg infused over 1 hour or by slow IV inj (at a rate of up to 12.5mg/min). Minimum cumulative dose: 1g given over 8 sequential dialysis sessions; usual max: 125mg/dose.

Children Dosage:

<6yrs: not recommended. Give by IV infusion (diluted) over 1 hour. ≥6yrs: 1.5mg/kg per dose at 8 sequential dialysis sessions; max: 125mg/dose.

NULECIT Contraindications:

Anemias not caused by iron deficiency. Iron overload.

NULECIT Warnings/Precautions:

Hemoglobinopathies. Refractory anemias. Avoid in neonates. Pregnancy (Cat. B). Nursing mothers.

NULECIT Classification:


NULECIT Interactions:

May reduce absorption of concomitant oral iron preparations.

Adverse Reactions:

Hypotension, hypertension, GI upset, chest pain, back pain, abdominal pain, pruritus, inj site reaction, cramps, headache, dizziness, syncope, fatigue, fever, dyspnea, tachycardia; rare: hypersensitivity reactions.

How Supplied:

Vials (5mL)—10